RT Journal Article
SR Electronic
T1 Patient stratification reveals the molecular basis of disease comorbidities
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.22.21260979
DO 10.1101/2021.07.22.21260979
A1 Urda-García, Beatriz
A1 Sánchez-Valle, Jon
A1 Lepore, Rosalba
A1 Valencia, Alfonso
YR 2021
UL http://medrxiv.org/content/early/2021/07/24/2021.07.22.21260979.abstract
AB Epidemiological evidence shows that some diseases tend to co-occur; more exactly, certain groups of patients with a given disease are at a higher risk of developing a specific secondary condition. Despite the considerable interest, only a small number of connections between comorbidities and molecular processes have been identified.Here we develop a new approach to generate a disease network that uses the accumulating RNA-seq data on human diseases to significantly match a large number of known comorbidities, providing plausible biological models for such co-occurrences. Furthermore, 64% of the known disease pairs can be explained by analysing groups of patients with similar expression profiles, highlighting the importance of patient stratification in the study of comorbidities.These results solidly support the existence of molecular mechanisms behind many of the known comorbidities. All the information can be explored on a large scale and in detail at http://disease-perception.bsc.es/rgenexcom/.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been supported by the Ph.D. Fellowship (PRE2019-090454) and funded by the Spanish Ministry of Economics and Competitiveness (RTI2018-096653-B-I00). J.S.-V. was supported by the PhD fellowship BES-2016-077403.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code of the experiments is available at https://github.com/beatrizurda/Urda-Garcia_et_al_2021 and the code of the web application can be found at https://github.com/bsc-life/rgenexcom. The data is publicly available (Supplementary Data 1); the raw data can be downloaded from GEO (https://www.ncbi.nlm.nih.gov/geo/) and the counts can be downloaded from the GREIN platform (http://www.ilincs.org/apps/grein/). https://github.com/beatrizurda/Urda-Garcia_et_al_2021 https://github.com/bsc-life/rgenexcom https://www.ncbi.nlm.nih.gov/geo/ http://www.ilincs.org/apps/grein/